Beruflich Dokumente
Kultur Dokumente
VerDate Aug<31>2005 17:29 Dec 06, 2006 Jkt 211001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\07DEN1.SGM 07DEN1
Federal Register / Vol. 71, No. 235 / Thursday, December 7, 2006 / Notices 70987
a basic class of controlled substance Drug Schedule DEA to manufacture such a substance
listed in schedule II. may file comments or objections to the
The company plans to manufacture a Morphine (9300) ........................... II issuance of the proposed registration
cocaine derivative to be used in Oxycodone (9143) ........................ II pursuant to 21 CFR 1301.33(a).
domestic and foreign clinical research Meperidine (9230) ........................ II Any such written comments or
studies. Methadone (9250) ........................ II objections being sent via regular mail
No comments or objections have been Oxymorphone (9652) ................... II
should be addressed, in quintuplicate,
received. DEA has considered the to the Deputy Assistant Administrator,
The company plans to manufacture
factors in 21 U.S.C. 823(a) and Office of Diversion Control, Drug
the listed controlled substances in bulk
determined that the registration of MGI Enforcement Administration,
to manufacture controlled substance
Pharma to manufacture the listed basic Washington, DC 20537, Attention: DEA
derivatives. These derivatives will be
class of controlled substance is Federal Register Representative/ODL; or
used in diagnostic products created
consistent with the public interest at any being sent via express mail should
specifically for internal use only.
this time. DEA has investigated MGI be sent to DEA Headquarters, Attention:
No comments or objections have been
Pharma to ensure that the company’s DEA Federal Register Representative/
received. DEA has considered the
registration is consistent with the public ODL, 2401 Jefferson-Davis Highway,
factors in 21 U.S.C. 823(a) and
interest. The investigation has included Alexandria, Virginia 22301; and must be
determined that the registration of
inspection and testing of the company’s filed no later than February 5, 2007.
Orasure Technologies, Inc. to
physical security systems, verification
manufacture the listed basic classes of Dated: November 28, 2006.
of the company’s compliance with State
controlled substances is consistent with Joseph T. Rannazzisi,
and local laws, and a review of the
the public interest at this time. DEA has Deputy Assistant Administrator, Office of
company’s background and history. investigated Orasure Technologies, Inc. Diversion Control, Drug Enforcement
Therefore, pursuant to 21 U.S.C. 823, to ensure that the company’s Administration.
and in accordance with 21 CFR 1301.33, registration is consistent with the public [FR Doc. E6–20698 Filed 12–6–06; 8:45 am]
the above named company is granted interest. The investigation has included BILLING CODE 4410–09–P
registration as a bulk manufacturer of inspection and testing of the company’s
the basic class of controlled substance physical security systems, verification
listed. of the company’s compliance with State DEPARTMENT OF JUSTICE
Dated: November 28, 2006. and local laws, and a review of the
Joseph T. Rannazzisi, company’s background and history. Drug Enforcement Administration
Deputy Assistant Administrator, Office of Therefore, pursuant to 21 U.S.C. 823,
Diversion Control, Drug Enforcement and in accordance with 21 CFR 1301.33, Importer of Controlled Substances;
Administration. the above named company is granted Notice of Registration
[FR Doc. E6–20689 Filed 12–6–06; 8:45 am] registration as a bulk manufacturer of By Notice dated August 7, 2006 and
BILLING CODE 4410–09–P the basic classes of controlled published in the Federal Register on
substances listed. August 15, 2006, (71 FR 46922), Penick
Dated: November 28, 2006. Corporation, 33 Industrial Park Road,
DEPARTMENT OF JUSTICE Pennsville, New Jersey 08070, made
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of application by renewal to the Drug
Drug Enforcement Administration
Diversion Control, Drug Enforcement Enforcement Administration (DEA) to
Manufacturer of Controlled Administration. be registered as an importer of the basic
Substances; Notice of Registration [FR Doc. E6–20744 Filed 12–6–06; 8:45 am] classes of controlled substances listed in
BILLING CODE 4410–09–P schedule II:
By Notice dated July 26, 2006, and
published in the Federal Register on Drug Schedule
August 2, 2006, (71 FR 43814), Orasure DEPARTMENT OF JUSTICE
Technologies, Inc., Lehigh University, Coca Leaves (9040) ..................... II
Seeley G. Mudd-Building 6, Bethlehem, Drug Enforcement Administration Raw Opium (9600) ....................... II
Poppy Straw (9650) ..................... II
Pennsylvania 18015, made application
Manufacturer of Controlled Concentrate of Poppy Straw II
by renewal to the Drug Enforcement (9670).
Administration (DEA) to be registered as Substances; Notice of Application
a bulk manufacturer of the basic classes Pursuant to § 1301.33(a) of Title 21 of The company plans to import the
of controlled substances listed in the Code of Federal Regulations (CFR), listed controlled substances to
schedules I and II: this is notice that on September 20, manufacture bulk controlled substance
2006, Organix Inc., 240 Salem Street, intermediates for sale to its customers.
Drug Schedule No comments or objections have been
Woburn, Massachusetts 01801, made
Lysergic acid diethylamide (LSD) I application by renewal to the Drug received. DEA has considered the
(7315). Enforcement Administration (DEA) to factors in 21 U.S.C. 823(a) and 952(a)
4–Methoxyamphetamine (7411) ... I be registered as a bulk manufacturer of and determined that the registration of
Normorphine (9313) ..................... I Cocaine (9041), a basic class of Penick Corporation to import the basic
Tetrahydrocannabinols (THC) I controlled substance listed in schedule classes of controlled substances is
(7370). II. consistent with the public interest and
Alphamethadol (9605) .................. I The company plans to manufacture a with United States obligations under
Amphetamine (1100) .................... II international treaties, conventions, or
Methamphetamine (1105) ............ II
chemical that is a derivative of cocaine
Cocaine (9041) ............................. II that will be sold to their customer for protocols in effect on May 1, 1971, at
Hydromorphone (9150) ................ II research purposes. this time. DEA has investigated Penick
Benzoylecgonine (9180) ............... II Any other such applicant and any Corporation to ensure that the
Hydrocodone (9193) ..................... II person who is presently registered with company’s registration is consistent
VerDate Aug<31>2005 17:29 Dec 06, 2006 Jkt 211001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\07DEN1.SGM 07DEN1